Please login to the form below

Not currently logged in

Pharma market access [infographic]

A 12 step process for preparing a pharma brand for market

Pharma market access infographic

There is no 'one' definition of market access – the idea of which varies from company to company; region to region.

But while there may not be consensus on the exact wording – which spans everything from 'stakeholders' to 'accelerate market uptake', 'optimising value' and 'pricing and reimbursement' – most agree that it is not a 'discipline' that can be packaged neatly into a silo.

Inside: Market Access, a new publication from PMLiVE's publishers PMGroup, provides expert thinking on the area and includes a unique market access road map.

Download full size infographic on 12 steps to prepare a pharma brand for market (pdf - right click and select 'save link as')

Pharma market access reportThe publication, which PME subscribers received earlier this month, also looks at:

• Re-positioning pharma's image for market access success
• How to equip market access teams for local challenges
• The role of communication and education
• The true meaning of market access
• UK market access and the NHS
• How NICE is collaborating, and exporting its thinking, across Europe and beyond
• EU pricing and reimbursement, and reference pricing.

View Inside: Market Access online

28th June 2012


Featured jobs

Subscribe to our email news alerts


Add my company
S&H Medical Communications

S&H Medical Communications has a reputation for excellence, insight and energy. The collaborative team, from diverse backgrounds and supported by...

Latest intelligence

Revisiting Instagram for pharma
In pharma, Instagram usage is increasing because it offers so many benefits to engage with patients and HCPs...
The one multichannel question you must ask
There is a question every marketer should ask when designing a multichannel communications strategy...
Medius Deal Watch
Deal Watch September 2016
Abbott, Allergan, Celgene, Moderna, Pfizer and Takeda feature in this month's pharma deals round-up...